Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk - Takeaways - MDSpire

Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk

  • By

  • Alejandro Cisterna-Garcia

  • Bernabe I Bustos

  • Sara Bandres-Ciga

  • Thiago P Leal

  • Elif I Sarihan

  • Christie Jok

  • Dimitri Krainc

  • International Parkinson’s Disease Genomics Consortium (IPDGC)

  • Ignacio F Mata

  • Steven J Lubbe

  • Juan A Botia

  • December 9, 2024

  • 0 min

Share

  • 1

    The study developed VARI3, a genome-wide epistasis screening pipeline, to identify interactions linked to Parkinson's disease.

  • 2

    Using 14 cohorts of European ancestry, 14 significant candidate variant–variant interactions were identified in the discovery stage.

  • 3

    Three epistatic signals near SNCA and within MAPT and WNT3 were successfully replicated in four independent cohorts.

  • 4

    Admixture analysis revealed that the epistatic effects were present in individuals of both European and Native American ancestry.

  • 5

    The identified epistatic signals were enriched in pathways relevant to Parkinson's disease, highlighting their functional significance.

Original Source(s)

Related Content